13:30 - 13:50Hope for the future
Dr. Adolfo de la Fuente
MD Anderson Cancer Center Madrid, Spain
13:50 - 14:05Discussion
Chairs:
Dr. Elias Jabbour
MD Anderson Cancer Center, Houston, USA
Dr. Adolfo de la Fuente
MD Anderson Cancer Center Madrid, Spain
14:05 - 14:25First-line therapy of Ph-positive ALL: current status and perspectives
Dr. Sabina Chiaretti
Sapienza University, Rome, Italy
14:25 - 14:45Adult LAL: real-life treatment results
Dr. Josep Mª Ribera
Josep Carreras Leukemia Research Institute, Barcelona, Spain
14:45 - 15:05Optimizing 1st line therapy based on MRD in ALL
Dr. Elias Jabbour
MD Anderson Cancer Center, Houston, USA
15:05 - 15:25Introducing Inotuzumab in day to day practice
Dr. Claudio Cerchione
Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) IRCCS, Meldola, Italy
15:25 - 15:40Discussion
Chairs:
Dr. Miguel Ángel Sanz
Hospital Universitario y Politécnico La Fe. Valencia, Spain
Dr. Adolfo de la Fuente
MD Anderson Cancer Center Madrid, Spain
15:55 - 16:15AML management ELN 2017 update
Dr. Hartmut Döhner
Universitätsklinikum Ulm, Germany
16:15 - 16:35Moving toward targeted approaches in AML
Dr. Richard Stone
Dana-Farber Cancer Institute, Boston, USA
16:35 - 16:55Update in Bcl2 inhibitors
Dr. Daniel Pollyea
University of Colorado School of Medicine, USA
16:55 - 17:10Discussion
Chairs:
Dr. Miguel Ángel Sanz
Hospital Universitario y Politécnico La Fe, Valencia, Spain
Dr. Naval Daver,
MD Anderson Cancer Center, Houston, USA
17:25 - 17:45Immunotherapy in ALL
Dr. Elias Jabbour
MD Anderson Cancer Center, Houston, USA
17:45 - 18:05Harnessing the immune system for threating AML
Dr. Naval Daver
MD Anderson Cancer Center, Houston, USA
18:05 - 18:25CAR-T cell: organization and start-up of a unit
Dr. Manuel Guerreiro
Hospital Universitario y Politécnico La Fe. Valencia, Spain
18:25 - 18:45CAR-T cell therapy in adult patients with ALL
Dr. Nicolas Boissel
Hôpital Saint-Louis, Paris, France
18:45 - 19:05Immunotherapy approaches in MDS
Dr. Guillermo García-Manero
MD Anderson Cancer Center, Houston, USA
19:05 - 19:20Discussion